SLC5A2 and hydrops fetalis: The observed reductions in NT-proBNP in DEFINE-HF and EMPULSE, together with the robust reverse remodeling documented in EMPA-TROPISM, provide converging evidence that SGLT2 inhibitors exert meaningful hemodynamic and myocardial effects beyond glycemic control.